Lumen Bioscience Launches Phase I Trial of Oral Biologic Drug for Preventing C. difficile Infection Recurrence
Lumen Bioscience, a clinical-stage biopharmaceutical company developing biologic drugs for highly prevalent diseases, today announced…
dcorriganSeptember 3, 2021










